New additional functions of ApoE on multiple amyloid beta (Aβ) -related or-independent pathways have been recognized (Raulin et al., 2022), opening the possibility of designing new effective ApoE-targeted therapeutic strategies for AD. This evidence concerns the gene APOE and Alzheimer disease.